Lịch sử
mua hàng
The modern era has witnessed a dramatic rise in health consciousness, with weight management becoming one of the key areas of focus for consumers globally. The increasing prevalence of obesity and its associated health risks, such as diabetes and cardiovascular diseases, has amplified the urgency to adopt effective and sustainable fat loss solutions.

According to a 2021 report by FMCG Guru, 31% of global consumers reported they were actively dieting to lose weight. The impact of the COVID-19 pandemic further shaped consumer behavior, as health awareness surged. A 2021 Mintel report revealed that 48% of American consumers cited avoiding health risks linked to obesity as the primary motivation behind their weight loss efforts.
Consumers today are not only seeking methods that work but also products that align with natural, safe, and science-backed principles for fat loss.
By addressing the root causes of excess fat storage and offering long-lasting benefits, Sinetrol® can bridge the gap between consumer expectations and real-world results.

What sets Sinetrol® apart is its focus on bioavailability. Many polyphenol-rich products face challenges in delivering their active compounds to the body in usable forms. Sinetrol® overcomes this by using a carefully optimized extraction and formulation process, ensuring that its compounds remain highly bioavailable and effective.
Sinetrol® is supported by four published clinical trials involving over 300 subjects. The results consistently show significant reductions in body fat mass, waist circumference, and hip circumference—all without a loss of lean muscle mass. Most notably, the benefits extend beyond the supplementation period, with subjects maintaining improved body composition a month after ceasing Sinetrol® intake.

Sinetrol® operates at the cellular level, specifically targeting adipocytes, based on the exclusive patented mechanism FST (Fat Shredding Technology®). This unique mechanism focuses on enhancing lipolysis—the breakdown of fat—and mimicking the natural transformation of white fat cells into beige fat cells, shifting them from energy-storing cells to metabolism-driven cells. By doing so, Sinetrol® not only reduces existing fat stores but also prevents further fat storage, supporting sustainable weight management.
Sinetrol® significantly boosts the physiological process of lipolysis, which is the breakdown of triglycerides stored in fat cells into free fatty acids (FFAs) and glycerol. This process is amplified through the inhibition of PDE-3 (phosphodiesterase-3). By inhibiting PDE-3, Sinetrol® raises the levels of cyclic AMP (cAMP) within adipocytes. Elevated cAMP levels activate hormone-sensitive lipase (HSL), an enzyme that catalyzes the breakdown of triglycerides, resulting in the release of FFAs. This step effectively mobilizes fat stores, making them available for energy use, and represents a pivotal point in reducing fat accumulation.
Once FFAs are released, Sinetrol® ensures that they are efficiently metabolized rather than re-stored in fat tissue. This is achieved through the promotion of uncoupling protein (UCP) expression in beige adipose tissue. The increased cAMP levels triggered by Sinetrol® stimulate the upregulation of UCPs, which play a critical role in converting FFAs into heat via thermogenesis. This process dissipates energy instead of allowing it to be stored as fat.

One of Sinetrol®’s most compelling benefits is its ability to increase resting energy expenditure (REE). REE accounts for the majority of daily calorie burn, and boosting it can lead to significant fat loss over time. By enhancing mitochondrial activity in adipocytes, Sinetrol® ensures that the body burns more calories even at rest, creating a sustainable pathway for weight management.
Unlike many weight loss solutions that indiscriminately reduce both fat and muscle mass, Sinetrol® specifically targets fat stores while preserving lean tissue. This is critical for long-term health, as lean mass plays a vital role in maintaining metabolic rate and physical strength.

One of the outstanding elements of Sinetrol® is the benefits lasting 1 month after the end of the supplementation. Clinical studies have shown that participants continued to maintain benefits such as reduced fat mass and improved body proportions one month after stopping use.
This is mainly due to the impact of Sinetrol® on the process of “beiging” of adipose tissue, promoting the body to maintain a more efficient metabolic state even when no longer supplemented.
Sinetrol® has been available on the market since 2005 and has been widely used with over 350 million doses distributed globally. Notably, from 2008 to 2022, no adverse events related to Sinetrol® supplementation have been recorded. This is strong evidence of the product's safety and reliability over nearly two decades.
Moreover, Sinetrol® is derived entirely from natural sources, ensuring its safety for consumers. Clinical studies spanning 16 weeks have also confirmed that Sinetrol® supplementation does not impact key biological or physiological parameters.

Sinetrol® is easily incorporated into functional food products in the form of capsules, powders, or dietary supplements. Flexible use and low dosage (from 630mg/day) help manufacturers easily develop products targeting consumers with healthy weight loss needs.
Manufacturers can use Sinetrol® to create products that bridge the gap between health and indulgence, such as fat-burning smoothies or protein bars. In the nutricosmetics space, Sinetrol® offers a unique angle by supporting body composition improvements that enhance overall appearance.
Sinetrol® stands out as a game-changing ingredient for long-term fat loss. Its proven efficacy, rooted in robust science, and its clean-label, sustainable formulation address the evolving needs of both businesses and consumers.